TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
AQST

Aquestive Therapeutics Inc

Healthcare · Drug Manufacturers - Specialty & Generic

4.60$ -1.1% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for Aquestive Therapeutics Inc (AQST): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/04/2026.

Next report 11/04/2026
Last report 08/11/2026
Earnings surprise by quarter (%)
Q3 23 · 72.7 % 23 Q4 23 · -28.6 % 23 Q1 24 · -112.5 % 24 Q2 24 · 90.9 % 24 Q3 24 · 8.3 % 24 Q4 24 · -21.3 % 24 Q1 25 · -37.5 % 25 Q2 25 · 29.4 % 25 Q3 25 · -7.7 % 25 Q4 25 · -100.0 % 25 Q1 26 · 61.5 % 26 Q2 26 · -80.0 % 26

EPS estimate beaten

Full history 14 of 35 quarters (40%)
Last 16 quarters 8 of 16 quarters (50%)

Earnings Call Transcripts

Search all transcripts →

  • 08/12/2026 Earnings Call Q2 2026 Open →
  • 05/14/2026 Earnings Call Q1 2026 Open →
  • 03/05/2026 Earnings Call Q4 2025 Open →
  • 11/06/2025 Earnings Call Q3 2025 Open →
  • 08/12/2025 Earnings Call Q2 2025 Open →
  • 05/13/2025 Earnings Call Q1 2025 Open →
  • 03/06/2025 Earnings Call Q4 2024 Open →
  • 11/05/2024 Earnings Call Q3 2024 Open →

News on This Stock

  • 09/17/2026 Aquestive Therapeutics, Inc. (AQST): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/11/2026 Aquestive Therapeutics, Inc. (AQST): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/10/2026 Aquestive Therapeutics, Inc. (AQST): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?